Skip to main content
. Author manuscript; available in PMC: 2018 May 15.
Published in final edited form as: Cancer. 2016 Nov 7;123(6):977–984. doi: 10.1002/cncr.30415

Figure 1. Survival analysis based on treatment.

Figure 1

Kaplan-Meier plots showing survival in months of patients with (dark teal) or without (light teal) optimal cytoreduction (A) or receiving neoadjuvant chemotherapy (NACT, dark teal) versus upfront surgery (light teal) (B). Log rank test was used to evaluate significance. The number of subjects at risk is indicated. p values shown on each graph.